V-Bio Ventures
Venture Capital
Active
Ghent, Belgium
36
28M
22
4.00
9
0.39
- Areas of investment
Summary
V-Bio Ventures is the famous VC, which was founded in 2015.
Besides them, we counted 4 critical employees of this fund in our database.
Speaking about the real fund results, this VC is 24 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2018. The fund is constantly included in 2-6 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the V-Bio Ventures, startups are often financed by The Yield Lab, The Institute for the Promotion of Innovation by Science and Technology in Flanders, Sham Innovation Santu00e9. The meaningful sponsors for the fund in investment in the same round are VIB, S.R.I.W., Pontifax. In the next rounds fund is usually obtained by Wellington Partners, VIB, The Institute for the Promotion of Innovation by Science and Technology in Flanders.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Genetics, Medical. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 3 of the founder, the chance for it to be financed is low. Among the various public portfolio startups of the fund, we may underline Aphea.Bio, OCTIMET Oncology, Syndesi Therapeutics
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- EUR 110000000
- Fund raised date
- 2022-03-31
Analytics
- Total investments
- 36
- Lead investments
- 9
- Rounds per year
- 4.00
- Follow on index
- 0.39
- Investments by industry
- Biotechnology (24)
- Health Care (18)
- Therapeutics (14)
- Medical (13)
- Pharmaceutical (5) Show 10 more
- Investments by region
-
- Belgium (19)
- France (6)
- United Kingdom (4)
- Denmark (1)
- Italy (1) Show 2 more
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 5
- Group Appearance index
- 0.83
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Immagene | 24 Apr 2024 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 23M | Noord-Holland, Amsterdam, The Netherlands |
| Protealis | 08 Apr 2021 | Early Stage Venture | 13M |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.